直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

Workshop

Life Sciences Workshop: Updates and Recent Trends in Pharmaceutical and Biotechnology Patent Law

July 18, 2019

Palo Alto, CA

This workshop addresses a diverse set of issues that are relevant to life sciences patent practitioners in protecting their own company’s products and patent portfolios and evaluating the portfolios of others. Specifically, we will offer the following presentations in this workshop:

  • Recent Developments Surrounding Standing, FDA Guidance on Interchangeability for Biologics, and Section 101 Subject Matter Eligibility in the Life Sciences
  • Patent Strategies for Inventions in the Life Sciences
  • Antibody Patenting
  • What Do Recent Cases Teach Us About Meeting the Written Description Requirement for Life Sciences and Biotechnology Inventions?
  • IP and Regulatory Considerations Regarding Cell Therapy

Speakers:
Paul Barker
Marta Garcia Daneshvar
Barbara Rudolph
Linda Wadler

Who Should Attend: General counsel and in-house patent counsel with responsibility for/interest in protecting a company’s intellectual property.

Date:
Thursday, July 18, 2019

Time:
12:30 - 5:30 p.m.

Location:
Palo Alto, CA

How to Register: To attend, please register online by Tuesday, July 16.

MCLE Credit: Finnegan confirms that this activity has been certified for 3.25 hours of California MCLE.

For questions or information on attending, please let us know.

Tags

antibodies, subject matter eligibility

Related Practices

Global IP Enforcement, Litigation, and Trials

Patent Litigation and Trials

Prosecution and Portfolio Management

Patent Drafting and Prosecution

Related Industries

Life Sciences

Pharmaceutical

Biotechnology

Biologics

Related Insights

Conference

Georgia Life Sciences Summit 2026

August 25-26, 2026

Sandy Springs

Conference

7th International Conference on Biofuels and Bioenergy

June 25-26, 2026

Edinburgh

Conference

17th Summit on Biosimilars & Innovator Biologics

June 2-3, 2026

New York

Articles

Article_D.-Mass-Patent-Litigation-Update-October-2024

D. Mass. Patent Litigation Update: April 2026

June 1, 2026

At the PTAB Blog

Consistency Is Key – USPTO Issues Three New Informative Decisions

May 29, 2026

Conference

BIA Start-up Festival

May 21, 2026

London

At the PTAB Blog

Before the Holding, the Message: Director Squires Uses Magnolia Medical to Outline PTAB Discretionary Denial Policy Changes

May 20, 2026

Conference

19th Annual Forum on Pharma & Biotech Patent Litigation in Europe

May 19-20, 2026

Amsterdam

Virtual Seminar

Patent "Basics" Seminar

May 19, 2026

Virtual

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP